PatientsVille.com Logo

Glakay Side Effects

PatientsVille

Common Glakay Side Effects


The most commonly reported Glakay side effects (click to view or check a box to report):

Pyrexia (6)
Pneumonia (5)
White Blood Cell Count Decreased (4)
Septic Shock (3)
Hypertension (3)
Cough (3)
Chest Pain (2)
Henoch-schonlein Purpura (2)
Aspartate Aminotransferase Increased (2)
Erythema Multiforme (2)
Hepatic Function Abnormal (2)
Decreased Appetite (2)
Chills (2)
Platelet Count Decreased (2)
Palmar-plantar Erythrodysaesthesia Syndrome (2)
Multi-organ Failure (2)
Pancytopenia (2)
Rash (2)
Renal Failure (2)
Serum Ferritin Increased (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Glakay Side Effects Reported to FDA



Glakay Side Effect Report#8463700-2
Febrile Neutropenia, Hypertension, Platelet Count Decreased, White Blood Cell Count Decreased, Serum Ferritin Increased, Neutrophil Count Decreased
This is a report of a male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Glakay (dosage: 45 Milligram, start time:
Jun 09, 2011), combined with:
  • Cefmetazole Sodium
  • Vidaza (75 Milligram/sq. Meter)
  • Vidaza (75 Milligram/sq. Meter)
  • Exjade
  • Decadron (4 Milligram)
  • Decadron (4 Milligram)
  • Decadron (4 Milligram)
  • Kytril (2 Milligram)
and developed a serious reaction and side effect(s): Febrile Neutropenia, Hypertension, Platelet Count Decreased, White Blood Cell Count Decreased, Serum Ferritin Increased, Neutrophil Count Decreased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Glakay treatment in male patients, resulting in Febrile Neutropenia side effect. The patient was hospitalized.
Glakay Side Effect Report#8413472-2
Decreased Appetite, Nasopharyngitis, Somnolence
This report suggests a potential Glakay Decreased Appetite side effect(s) that can have serious consequences. A 91-year-old female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: osteoporosis,oedema peripheral,constipation and used Glakay (dosage: NA) starting
Jun 14, 2011. After starting Glakay the patient began experiencing various side effects, including: Decreased Appetite, Nasopharyngitis, SomnolenceAdditional drugs used concurrently:
  • Lasix
  • Kamag G
  • Menatetrenone
  • Bisolvon
  • Rabeprazole Sodium
  • Livalo
  • Galantamine Hydrobromide
  • Rocaltrol
The patient was hospitalized. Although Glakay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Decreased Appetite, may still occur.
Glakay Side Effect Report#8236506-7
Renal Failure, Respiratory Failure, Septic Shock, Multi-organ Failure
This Renal Failure problem was reported by a physician from Japan. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Aug 20, 2011 this consumer started treatment with Glakay (dosage: 15 Mg, Tid). The following drugs were being taken at the same time:
  • Asacol (Unk)
  • Famotidine (20 Mg, Uid/qd)
  • Miya Bm (2 Df, Tid)
  • Prednisolone (6.25 Mg, Bid)
  • Prograf (3 Mg, Bid)
  • Ferrous Citrate (2 Df, Uid/qd)
  • Loperamide Hcl (1 Mg, Uid/qd)
When using Glakay, the patient experienced the following unwanted symptoms/side effects: Renal Failure, Respiratory Failure, Septic Shock, Multi-organ FailureAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Renal Failure, may become evident only after a product is in use by the general population.
Glakay Side Effect Report#8157065-3
Pancytopenia
This Pancytopenia side effect was reported by a physician from Japan. A female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Glakay (drug dosage: NA), which was initiated on
Sep 07, 2011. Concurrently used drugs:
  • Fosrenol
  • Mircera
  • Cinacalcet Hydrochloride
  • Rabeprazole Sodium
  • Urso 250
  • Risumic (In Front Of Hd)
  • Wasser V
  • Lac-b
.After starting to take Glakay the consumer reported adverse symptoms, such as: PancytopeniaThese side effects may potentially be related to Glakay. The patient was hospitalized.
Glakay Side Effect Report#8112720-6
Sepsis, Epistaxis, Cellulitis, Myelodysplastic Syndrome
This is a report of a female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Glakay (dosage: NA, start time:
Dec 01, 2011), combined with:
  • Alfarol
  • Pursennid
  • Magnesium Sulfate
  • Vidaza (75 Milligram/sq. Meter)
  • Vfend
  • Ciprofloxacin
  • Mucodyne
  • Vidaza (37.5 Milligram/sq. Meter)
and developed a serious reaction and side effect(s): Sepsis, Epistaxis, Cellulitis, Myelodysplastic Syndrome after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Glakay treatment in female patients, resulting in Sepsis side effect. The patient was hospitalized.
Glakay Side Effect Report#7954519-7
Cerebral Haemorrhage, Fall, Speech Disorder
This report suggests a potential Glakay Cerebral Haemorrhage side effect(s) that can have serious consequences. A female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Glakay (dosage: 45 Mg, Unk) starting
Jun 21, 2010. After starting Glakay the patient began experiencing various side effects, including: Cerebral Haemorrhage, Fall, Speech DisorderAdditional drugs used concurrently:
  • Cephadol (75 Mg, Unk)
  • Platibit (1 Ug, Unk)
  • Amlodipine Besylate/valsartan (1 Df, Daily)
The patient was hospitalized and became disabled. Although Glakay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Cerebral Haemorrhage, may still occur.
Glakay Side Effect Report#7781023-1
Septic Shock, Pneumonia, White Blood Cell Count Decreased
This Septic Shock problem was reported by a physician from Japan. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: myelodysplastic syndrome,prophylaxis,type 2 diabetes mellitus. On
Jun 01, 2009 this consumer started treatment with Glakay (dosage: 45 Mg, Unk). The following drugs were being taken at the same time:
  • Diflucan
  • Amaryl (1 Mg, Unk)
  • Diflucan (200 Mg, Unk)
  • Exjade (1000 Mg, Daily)
  • Lasix (10 Mg, Unk)
  • Aldactone (12.5 Mg, Unk)
  • Red Blood Cells, Concentrated (2 Units (every Week))
When using Glakay, the patient experienced the following unwanted symptoms/side effects: Septic Shock, Pneumonia, White Blood Cell Count DecreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Septic Shock, may become evident only after a product is in use by the general population.
Glakay Side Effect Report#7761998-7
Inflammatory Marker Increased, Pyrexia, Liver Disorder
This Inflammatory Marker Increased side effect was reported by a physician from Japan. A 62-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Glakay (drug dosage: Daily Dose 45 Mg), which was initiated on
Jun 16, 2011. Concurrently used drugs:
  • Nizatidine (Daily Dose 300 Mg)
  • Lamivudine (Daily Dose 100 Mg)
  • Amoban (Daily Dose 5 Mg)
  • Nexavar (400 Mg, Bid)
  • Aldactone (Daily Dose 50 Mg)
  • Acetaminophen (Daily Dose 400 Mg)
  • Lasix (Daily Dose 20 Mg)
  • Loxonin (Daily Dose 60 Mg)
.After starting to take Glakay the consumer reported adverse symptoms, such as: Inflammatory Marker Increased, Pyrexia, Liver DisorderThese side effects may potentially be related to Glakay. The patient was hospitalized.
Glakay Side Effect Report#7714491-1
Anaemia, Drowning, White Blood Cell Count Decreased, Mallory-weiss Syndrome, Hepatic Function Abnormal, Palmar-plantar Erythrodysaesthesia Syndrome, Hypertension
This is a report of a 65-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Glakay (dosage: Since Before Administration, start time:
Sep 25, 2009), combined with:
  • Allopurinol (Since Before Administration)
  • Fentanyl
  • Lansoprazole (15 Mg (daily Dose), , Oral)
  • Nexavar
  • Uralyt (Since Before Administration)
  • Fentanyl (Since Before Administration, 2.1/3mg)
  • Oxinorm (Since Before Administration)
  • Fentanyl (Since Before Administration, 4.2/3mg)
and developed a serious reaction and side effect(s): Anaemia, Drowning, White Blood Cell Count Decreased, Mallory-weiss Syndrome, Hepatic Function Abnormal, Palmar-plantar Erythrodysaesthesia Syndrome, Hypertension after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Glakay treatment in male patients, resulting in Anaemia side effect.
Glakay Side Effect Report#7648103-2
Ileus Paralytic, Constipation, Dysuria
This report suggests a potential Glakay Ileus Paralytic side effect(s) that can have serious consequences. A 64-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Glakay (dosage: NA) starting
May 16, 2011. After starting Glakay the patient began experiencing various side effects, including: Ileus Paralytic, Constipation, DysuriaAdditional drugs used concurrently:
  • Teleminsoft
  • Ondasetron
  • Vidaza (75 Milligram)
  • Alinamin-f
  • Vidaza (75 Milligram)
  • Magnesium Sulfate
  • Pantol
  • Primobolan
The patient was hospitalized. Although Glakay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Ileus Paralytic, may still occur.
Glakay Side Effect Report#7544466-7
White Blood Cell Count Decreased, Septic Shock, Pneumonia
This White Blood Cell Count Decreased problem was reported by a physician from Japan. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: myelodysplastic syndrome,iron overload,type 2 diabetes mellitus. On
Oct 30, 2007 this consumer started treatment with Glakay (dosage: 45 Mg, Unk). The following drugs were being taken at the same time:
  • Exjade (100 Mg)
  • Amaryl (1 Mg, Unk)
  • Lasix (10 Mg, Unk)
  • Red Blood Cells, Concentrated (2 Units (every Week))
  • Aldactone (12.5 Mg, Unk)
  • Diflucan (200 Mg, Unk)
  • Diflucan
When using Glakay, the patient experienced the following unwanted symptoms/side effects: White Blood Cell Count Decreased, Septic Shock, PneumoniaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as White Blood Cell Count Decreased, may become evident only after a product is in use by the general population.
Glakay Side Effect Report#7499213-4
Aspartate Aminotransferase Increased, Erythema Multiforme, Lip Erosion, Blood Creatine Phosphokinase Increased, Pyrexia, Alanine Aminotransferase Increased, Thrombocytopenia, Blood Albumin Decreased, Haemorrhage
This Aspartate Aminotransferase Increased side effect was reported by a physician from Japan. A 78-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Glakay (drug dosage: 45 Mg (daily Dose), , Oral), which was initiated on
Sep 21, 2009. Concurrently used drugs:
  • Urso 250 (600 Mg (daily Dose), , Oral)
  • Rabeprazole Sodium (10 Mg (daily Dose), , Oral)
  • Uft (300 Mg (daily Dose), , Oral)
  • Adjust-a (80 Mg (daily Dose), , Oral)
  • Livact (12.45 G (daily Dose), , Oral)
  • Falkamin (12.45 G (daily Dose), , Oral)
  • Magnesium Sulfate (1980 Mg (daily Dose), , Oral)
  • Nexavar
.After starting to take Glakay the consumer reported adverse symptoms, such as: Aspartate Aminotransferase Increased, Erythema Multiforme, Lip Erosion, Blood Creatine Phosphokinase Increased, Pyrexia, Alanine Aminotransferase Increased, Thrombocytopenia, Blood Albumin Decreased, HaemorrhageThese side effects may potentially be related to Glakay. The patient was hospitalized.
Glakay Side Effect Report#7347469-0
Neoplasm Malignant, Pneumonia, Pruritus, Gamma-glutamyltransferase Increased, Pancytopenia, Oral Pain, Serum Ferritin Increased, Toxic Epidermal Necrolysis, Erythema Multiforme
This is a report of a female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: myelodysplastic syndrome, who was treated with Glakay (dosage: 45 Mg, start time:
Sep 01, 2006), combined with:
  • Primobolan (Unk)
  • Exjade (1000 Mg, Qd)
  • Red Blood Cells (2 U, Unk)
and developed a serious reaction and side effect(s): Neoplasm Malignant, Pneumonia, Pruritus, Gamma-glutamyltransferase Increased, Pancytopenia, Oral Pain, Serum Ferritin Increased, Toxic Epidermal Necrolysis, Erythema Multiforme after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Glakay treatment in female patients, resulting in Neoplasm Malignant side effect. The patient was hospitalized.
Glakay Side Effect Report#7344729-4
Bronchitis, Bacterial Infection, Infection, Dehydration, Pyrexia, Multi-organ Failure, Cough, Blood Creatinine Increased, Renal Failure
This report suggests a potential Glakay Bronchitis side effect(s) that can have serious consequences. A female patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Glakay (dosage: 45 Mg, Unk) starting
Nov 13, 2009. After starting Glakay the patient began experiencing various side effects, including: Bronchitis, Bacterial Infection, Infection, Dehydration, Pyrexia, Multi-organ Failure, Cough, Blood Creatinine Increased, Renal FailureAdditional drugs used concurrently:
  • Exjade (500 Mg, Daily)
  • Neoral (100 Mg, Daily)
  • Desferal (500 Mg)
  • Neutrogin (2.50 Ug)
  • Clarithromycin (400 Mg)
  • Exjade (500 Mg Daily)
  • Neoral (75 Mg, Daily)
The patient was hospitalized. Although Glakay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Bronchitis, may still occur.
Glakay Side Effect Report#7310813-4
Platelet Count Decreased, Haematocrit Decreased, Vomiting, Red Blood Cell Count Decreased, Haemoglobin Decreased, Nausea
This Platelet Count Decreased problem was reported by a physician from Japan. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: prophylaxis. On
Mar 28, 2009 this consumer started treatment with Glakay (dosage: 45 Mg, Unk). The following drugs were being taken at the same time:
  • Red Blood Cells, Concentrated (02 Units Each Time)
  • Nasanyl (02 Df, Unk)
  • Exjade (1000 Mg Daily)
  • Takepron (15 Mg, Unk)
  • Adona (90 Mg, Unk)
  • Alfarol (03 Df, Unk)
  • Blood Transfusion, Auxiliary Products (Unk)
When using Glakay, the patient experienced the following unwanted symptoms/side effects: Platelet Count Decreased, Haematocrit Decreased, Vomiting, Red Blood Cell Count Decreased, Haemoglobin Decreased, NauseaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Platelet Count Decreased, may become evident only after a product is in use by the general population.
Glakay Side Effect Report#7249608-9
Hypertension, Insomnia, Hepatic Function Abnormal, Pollakiuria, Pyrexia
This Hypertension side effect was reported by a physician from Japan. A male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Glakay (drug dosage: Before Nexavar Administration), which was initiated on
Jul 27, 2010. Concurrently used drugs:
  • Mevalotin (Before Nexavar Administration)
  • Lendormin (0.25 Mg (daily Dose), , Oral)
  • Ursodeoxycholic Acid
  • Flivas (25 Mg (daily Dose), , Oral)
  • Allelock (Before Nexavar Administration)
  • Livact (Before Nexavar Administration)
  • Nexavar
  • Tryptanol (10 Mg (daily Dose), , Oral)
.After starting to take Glakay the consumer reported adverse symptoms, such as: Hypertension, Insomnia, Hepatic Function Abnormal, Pollakiuria, PyrexiaThese side effects may potentially be related to Glakay.
Glakay Side Effect Report#7232558-1
Hypoglycaemia, Palmar-plantar Erythrodysaesthesia Syndrome, Decreased Appetite
This is a report of a female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: osteoporosis,gastric ulcer,back pain,hypoalbuminaemia,diarrhoea, who was treated with Glakay (dosage: Daily Dose 45 Mg, start time:
Sep 03, 2009), combined with:
  • Gastrom (Daily Dose 3 G)
  • Celecoxib (Daily Dose 200 Mg)
  • Livact (Daily Dose 12.45 G)
  • Lacb-r (Daily Dose 3 G)
  • Omepral (Daily Dose 20 Mg)
  • Sorafenib (raf Kinase Inhibitor) (Daily Dose 800 Mg)
  • Lopemin (Daily Dose 2 Mg)
  • Tannalbin (Daily Dose 3 G)
and developed a serious reaction and side effect(s): Hypoglycaemia, Palmar-plantar Erythrodysaesthesia Syndrome, Decreased Appetite after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Glakay treatment in female patients, resulting in Hypoglycaemia side effect.
Glakay Side Effect Report#5635963-X
Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, Rash
This report suggests a potential Glakay Chest Pain side effect(s) that can have serious consequences. A 65-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: myelodysplastic syndrome and used Glakay (dosage: NA) starting
Jan 17, 2008. After starting Glakay the patient began experiencing various side effects, including: Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, RashAdditional drugs used concurrently:
  • Alfarol
  • Niflan
  • Neo-minophagen C
  • Loxonin
  • Exjade (1125 Mg, Qd)
The patient was hospitalized. Although Glakay demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Chest Pain, may still occur.
Glakay Side Effect Report#5632909-5
Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, Rash
This Chest Pain problem was reported by a physician from Japan. A 65-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: myelodysplastic syndrome. On
Jan 17, 2008 this consumer started treatment with Glakay (dosage: NA). The following drugs were being taken at the same time:
  • Alfarol
  • Niflan
  • Neo-minophagen C
  • Loxonin
  • Exjade (1125 Mg, Qd)
When using Glakay, the patient experienced the following unwanted symptoms/side effects: Chest Pain, Chills, Cough, Henoch-schonlein Purpura, Pneumonia, Pyrexia, RashThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Chest Pain, may become evident only after a product is in use by the general population.
Glakay Side Effect Report#4560578-4
Aspartate Aminotransferase Increased, Disease Recurrence, Gamma-glutamyltransferase Increased, Hepatitis C
This Aspartate Aminotransferase Increased side effect was reported by a physician from . A 66-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Glakay (drug dosage: 45 Mg, Unk), which was initiated on NS. Concurrently used drugs:
  • Urso 250 (600 Mg, Unk)
  • Cabagin-u (6 Df, Unk)
  • Diovan (40 Mg, Qd)
.After starting to take Glakay the consumer reported adverse symptoms, such as: Aspartate Aminotransferase Increased, Disease Recurrence, Gamma-glutamyltransferase Increased, Hepatitis CThese side effects may potentially be related to Glakay. The patient was hospitalized.



The appearance of Glakay on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Ask a Doctor Online
12 Doctors are Online.
A Question is Answered Every 9 Seconds!
Ask a Doctor >

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Glakay reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Ask a Doctor Online
    12 Doctors are Online.
    A Question is Answered Every 9 Seconds!
    Ask a Doctor >

    Discuss Glakay Side Effects

    Did You Have a Glakay Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Glakay for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Glakay Safety Alerts, Active Ingredients, Usage Information

    More About Glakay

    Side Effects reported to FDA: 20

    Glakay safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 15

    Latest Glakay clinical trials

    Glakay Reviews

    No reviews, be a first to report a side effect via side effect reporting form